Premium
Classification of tubulo‐papillary renal cortical tumours using estimates of nuclear volume
Author(s) -
BROOKS BRENDA,
SØRENSEN FLEMMING BRANDT,
OLSEN STEEN,
HOLMNIELSEN PETER
Publication year - 1993
Publication title -
apmis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.909
H-Index - 88
eISSN - 1600-0463
pISSN - 0903-4641
DOI - 10.1111/j.1699-0463.1993.tb00124.x
Subject(s) - medicine , pathology , volume (thermodynamics) , anatomy , physics , quantum mechanics
The classification of renal cortical tumours is problematic, with no clear division of benign from malignant tumours. Unbiased stereological estimates of volume‐weighted nuclear volume ( nuclear v̄ v ) were obtained by point sampling of nuclear intercepts in a retrospective study of 36 variably sized tubulo‐papillary basophilic cell renal cortical tumours. There was no clear pattern of evolution of nuclear v̄ v with increasing macroscopic tumour diameter. Estimates of nuclear v̄ v could not distinguish between 21 tumours classified as renal adenomas with macroscopic diameters < 3 cm (average nuclear v̄ v = 241 μm 3 ) and 15 tumours classified as renal cell carcinomas with diameters > 3 cm, or aggressive histological pattern (average nuclear v̄ v = 229 μm 3 ) (2 p = 0.68). In this subtype of renal cortical tumours, estimates of nuclear v̄ v do not support the historical convention of using a 3 cm tumour diameter as the dividing line between adenomas and carcinomas, but support the theory of a single group of tumours. As most of the truly incidental renal cortical tumours are less than 1 cm in diameter, this limit could be considered. Such small benign cortical nodules have never been reported to metastasize, and would thus be excluded from being diagnosed and registered as malignant. Although this dividing line is again arbitrary, and cannot be justified by the stereological measurements, it is a practical solution to a clinical problem. There were too few examples of disease progression to assess the prognostic significance of nuclear v̄ v in these tumours.